NSETrading Window26 Jun 2026 · 26 Jun 2026, 02:37 pm
Trading Window
Marksans Pharma Limited · MARKSANS
✦ AI Summary
Marksans Pharma Limited has informed the Exchange regarding the closure of the trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
MARKSANS_26062026143659_Closure_of_Trading_Window.pdf
View document text
June 26, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400001. Bandra (East), Mumbai - 400051.
Scrip Code: 524404 Symbol: MARKSANS
Subject: Intimation of closure of Trading Window in terms of SEBI (Prohibition of Insider Trading)
Regulations, 2015
Dear Sir/Madam,
In terms of the Company's code of conduct to regulate, monitor and report trading by designated
persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the
trading window for dealing in the shares of Marksans Pharma Limited (‘the Company’) by the
designated persons of the Company and their immediate relatives will remain closed from
Wednesday, July 01, 2026 till 48 hours after the declaration of unaudited financial results for the
quarter ended June 30, 2026. The date of declaration of financial results will be intimated separately
in due course of time.
Designated Persons of the Company and their immediate relatives shall not trade in the shares of
the Company during the aforesaid period of closure of trading window.
You are requested to note the above in your records.
Thanking You.
Yours faithfully,
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W),
Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: companysecretary@marksanspharma.com
www.marksanspharma.com